Related Experiment Video
Updated: Jul 19, 2025
07:29
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
19.7K
An inter-specialty cancer training programme curriculum for Europe
Kim Benstead1, Andreas Brandl2, Ton Brouwers3
1Gloucestershire Hospitals NHS Foundation Trust, Cheltenham, UK.
Summary
The INTERACT-EUROPE Project developed an inter-specialty cancer training curriculum to enhance patient care. This pilot program equips healthcare professionals with essential competencies for improved cancer treatment outcomes.
Area of Science:
- Oncology Education
- Multidisciplinary Cancer Care
Background:
- Multidisciplinary collaboration is crucial for optimal patient outcomes in cancer care.
- The INTERACT-EUROPE Project aimed to create an inter-specialty curriculum to address cancer training needs.
Approach:
- A scoping review and mixed-methods surveys (qualitative and quantitative) were conducted.
- Stakeholder input was gathered through surveys, meetings, and a consultative document.
- Competencies were evaluated using a 7-point Likert scale by relevant professional bodies.
Key Points:
- The curriculum was structured around the CanMEDS framework, including 13 Entrustable Professional Activities and 127 enabling competencies.
- Competencies were refined based on feedback, with revisions, additions, and omissions.
- Recommendations for program infrastructure, organization, content, and assessment were formulated.
Conclusions:
- An Inter-specialty Cancer Training Programme Curriculum and a pilot program were successfully developed.
- The initiative aims to improve the care of individuals affected by cancer through enhanced training.
Related Concept Videos
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
01:30Cancer Vaccines
403
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
403
01:27Tumor Immunotherapy
557
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
557
01:21Cancer Survival Analysis
384
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
384
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K